<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02314806</url>
  </required_header>
  <id_info>
    <org_study_id>HGUE 2014-12</org_study_id>
    <nct_id>NCT02314806</nct_id>
  </id_info>
  <brief_title>Gentamicin Versus Clindamycin Versus Normal Saline Lavage in Axilla</brief_title>
  <official_title>Effect of Gentamicin Versus Clindamycin Versus Normal Saline Lavage of the Axillary Surgical Bed After Lymph Node Dissection on Drainage Discharge Volume</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital General Universitario Elche</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital General Universitario Elche</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The patients undergoing axillary lymph node dissection were randomized into 3 groups:
      patients undergoing lavages with normal saline (Group 1), patients undergoing lavage
      gentamicin solution (Group 2) and patients undergoing lavage with a clindamycin solution
      (Group 3). Drainage volume discharge is investigated
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The patients undergoing axillary lymph node dissection were randomized into 3 groups:
      patients undergoing 2 lavages with 500 ml normal saline (Group 1), patients first undergoing
      lavage with 500 ml normal saline followed by a second lavage with a 500 ml of a gentamicin
      (240 mg) solution (Group 2) and patients first undergoing lavage with 500 ml normal saline
      followed by a second lavage with 500ml of a clindamycin (600mg) solution (Group 3). Drainage
      volume discharge is investigated
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Drainage volume discharge</measure>
    <time_frame>14 days</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Irrigation with Gentamicin solution</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The surgical bed is irrigated with a gentamicin solution</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Irrigation with Clindamycin solution</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The surgical bed is irrigated with a clindamycin solution</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Irrigation with Normal saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The surgical bed is irrigated with normal saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Irrigation with gentamicin solution</intervention_name>
    <description>The surgical bed is irrigated with a gentamicin solution</description>
    <arm_group_label>Irrigation with Gentamicin solution</arm_group_label>
    <other_name>Irrigation of the surgical bed with gentamicin solution</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Irrigation with Clindamycin solution</intervention_name>
    <description>The surgical bed is irrigated with a clindamycin solution</description>
    <arm_group_label>Irrigation with Clindamycin solution</arm_group_label>
    <other_name>Irrigation of the surgical bed with Clindamycin solution</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Irrigation with Normal saline</intervention_name>
    <description>The surgical bed is irrigated with normal saline</description>
    <arm_group_label>Irrigation with Normal saline</arm_group_label>
    <other_name>Irrigation of the surgical bed with normal saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosis of breast neoplasms

          -  plans to undergo an elective ALND of Berg's levels I and II due to axillary metastasis
             determined preoperatively by core biopsy or evidence of metastasis in the SLNB in the
             intraoperative or in the differed analysis.

        Exclusion Criteria:

          -  allergy to any of the antibiotic drugs used

          -  chronic renal failure due to possible toxicity of gentamicin

          -  patients undergoing a modified radical mastectomy.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jaime Ruiz-Tovar, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital General de Elche</affiliation>
  </overall_official>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 7, 2014</study_first_submitted>
  <study_first_submitted_qc>December 9, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 11, 2014</study_first_posted>
  <last_update_submitted>December 9, 2014</last_update_submitted>
  <last_update_submitted_qc>December 9, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 11, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital General Universitario Elche</investigator_affiliation>
    <investigator_full_name>Jaime Ruiz-Tovar, MD, PhD</investigator_full_name>
    <investigator_title>Medicine Doctor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Clindamycin</mesh_term>
    <mesh_term>Clindamycin palmitate</mesh_term>
    <mesh_term>Clindamycin phosphate</mesh_term>
    <mesh_term>Gentamicins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

